D. Bowen and C. Walker, Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, vol.38, issue.7053, pp.946-52, 2005.
DOI : 10.1128/JVI.78.3.1575-1581.2004

T. Von-hahn, J. Yoon, and H. Alter, Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo, Gastroenterology, vol.132, issue.2
DOI : 10.1053/j.gastro.2006.12.008

Z. Keck, S. Li, and J. Xia, Mutations in HCV E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity, J Virol, 2009.

P. Pileri, Y. Uematsu, and S. Campagnoli, Binding of Hepatitis C Virus to CD81, Science, vol.282, issue.5390, pp.938-979, 1998.
DOI : 10.1126/science.282.5390.938

E. Scarselli, H. Ansuini, and R. Cerino, The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus, The EMBO Journal, vol.269, issue.19, pp.5017-5025, 2002.
DOI : 10.1093/emboj/cdf529

D. Akazawa, T. Date, and K. Morikawa, CD81 Expression Is Important for the Permissiveness of Huh7 Cell Clones for Heterogeneous Hepatitis C Virus Infection, Journal of Virology, vol.81, issue.10, pp.5036-5045, 2007.
DOI : 10.1128/JVI.01573-06

G. Koutsoudakis, A. Kaul, and E. Steinmann, Characterization of the Early Steps of Hepatitis C Virus Infection by Using Luciferase Reporter Viruses, Journal of Virology, vol.80, issue.11, pp.5308-5328, 2006.
DOI : 10.1128/JVI.02460-05

M. Zeisel, G. Koutsoudakis, and E. Schnober, Scavenger receptor BI is a key host factor for Hepatitis C virus infection required for an entry step closely linked to CD81

M. Evans, T. Von-hahn, and D. Tscherne, Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry, Nature, vol.23, issue.7137, pp.801-806, 2007.
DOI : 10.1038/nature05654

L. Meertens, C. Bertaux, and L. Cukierman, The Tight Junction Proteins Claudin-1, -6, and -9 Are Entry Cofactors for Hepatitis C Virus, Journal of Virology, vol.82, issue.7, pp.3555-60, 2008.
DOI : 10.1128/JVI.01977-07

A. Ploss, M. Evans, and V. Gaysinskaya, Human occludin is a hepatitis C virus entry factor required for infection of mouse cells, Nature, vol.309, issue.7231, pp.882-888, 2009.
DOI : 10.1038/nature07684

M. Dreux, D. Thi, V. Fresquet, and J. , Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains, PLoS Pathogens, vol.100, issue.2, pp.1000310-2009
DOI : 10.1371/journal.ppat.1000310.s005

F. Helle and J. Dubuisson, Hepatitis C virus entry into host cells, Cellular and Molecular Life Sciences, vol.65, issue.1, pp.100-112, 2008.
DOI : 10.1007/s00018-007-7291-8

T. Von-hahn and C. Rice, Hepatitis C Virus Entry, Journal of Biological Chemistry, vol.283, issue.7, pp.3689-93, 2008.
DOI : 10.1074/jbc.R700024200

T. Wakita, T. Pietschmann, and T. Kato, Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nature Medicine, vol.37, issue.7, pp.791-797, 2005.
DOI : 10.1002/jmv.10297

T. Baumert, S. Ito, D. Wong, and T. Liang, Hepatitis C virus structural proteins assemble into viruslike particles in insect cells, J Virol, vol.72, pp.3827-3863, 1998.

H. Barth, R. Cerino, and M. Arcuri, Scavenger Receptor Class B Type I and Hepatitis C Virus Infection of Primary Tupaia Hepatocytes, Journal of Virology, vol.79, issue.9, pp.5774-85, 2005.
DOI : 10.1128/JVI.79.9.5774-5785.2005

S. Wellnitz, B. Klumpp, and H. Barth, Binding of Hepatitis C Virus-Like Particles Derived from Infectious Clone H77C to Defined Human Cell Lines, Journal of Virology, vol.76, issue.3, pp.1181-93, 2002.
DOI : 10.1128/JVI.76.3.1181-1193.2002

B. Bartosch, J. Dubuisson, and F. Cosset, Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1???E2 Envelope Protein Complexes, The Journal of Experimental Medicine, vol.72, issue.5, pp.633-675
DOI : 10.1093/emboj/21.12.2893
URL : https://hal.archives-ouvertes.fr/inserm-00133783

M. Hsu, J. Zhang, and M. Flint, Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles, Proceedings of the National Academy of Sciences, vol.100, issue.12, pp.7271-7276, 2003.
DOI : 10.1073/pnas.0832180100

B. Lindenbach, M. Evans, and A. Syder, Complete Replication of Hepatitis C Virus in Cell Culture, Science, vol.309, issue.5734, pp.623-629, 2005.
DOI : 10.1126/science.1114016

J. Zhong, P. Gastaminza, and G. Cheng, Robust hepatitis C virus infection in vitro, Proceedings of the National Academy of Sciences, vol.102, issue.26, pp.9294-9303, 2005.
DOI : 10.1073/pnas.0503596102

A. Haberstroh, E. Schnober, and M. Zeisel, Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Postbinding Steps and Membrane Fusion, Gastroenterology, vol.135, issue.5
DOI : 10.1053/j.gastro.2008.07.018

D. Rosa, S. Campagnoli, and C. Moretto, A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2

B. Bartosch, G. Verney, and M. Dreux, An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies, Journal of Virology, vol.79, issue.13, pp.8217-8246, 2005.
DOI : 10.1128/JVI.79.13.8217-8229.2005
URL : https://hal.archives-ouvertes.fr/hal-00313682

D. Steinmann, H. Barth, and B. Gissler, Inhibition of Hepatitis C Virus-Like Particle Binding to Target Cells by Antiviral Antibodies in Acute and Chronic Hepatitis C, Journal of Virology, vol.78, issue.17, pp.9030-9040, 2004.
DOI : 10.1128/JVI.78.17.9030-9040.2004

A. Owsianka, A. Tarr, and V. Juttla, Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein, Journal of Virology, vol.79, issue.17, pp.11095-104, 2005.
DOI : 10.1128/JVI.79.17.11095-11104.2005

P. Zhang, C. Wu, and K. Mihalik, Hepatitis C virus epitope-specific neutralizing antibodies in Igs prepared from human plasma, Proceedings of the National Academy of Sciences, vol.104, issue.20, pp.8449-54, 2007.
DOI : 10.1073/pnas.0703039104

J. Zhang, G. Randall, A. Higginbottom, P. Monk, C. Rice et al., CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection, Journal of Virology, vol.78, issue.3, pp.1448-55, 2004.
DOI : 10.1128/JVI.78.3.1448-1455.2004

A. Owsianka, J. Timms, and A. Tarr, Identification of Conserved Residues in the E2 Envelope Glycoprotein of the Hepatitis C Virus That Are Critical for CD81 Binding, Journal of Virology, vol.80, issue.17, pp.8695-704, 2006.
DOI : 10.1128/JVI.00271-06

F. Habersetzer, A. Fournillier, and J. Dubuisson, Characterization of Human Monoclonal Antibodies Specific to the Hepatitis C Virus Glycoprotein E2 within VitroBinding Neutralization Properties, Virology, vol.249, issue.1, pp.32-41, 1998.
DOI : 10.1006/viro.1998.9202

Z. Keck, O. De-beeck, A. Hadlock, and K. , Hepatitis C Virus E2 Has Three Immunogenic Domains Containing Conformational Epitopes with Distinct Properties and Biological Functions, Journal of Virology, vol.78, issue.17, pp.9224-9256, 2004.
DOI : 10.1128/JVI.78.17.9224-9232.2004

D. Schofield, B. Bartosch, and Y. Shimizu, Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity, Hepatology, vol.78, issue.7959
DOI : 10.1002/hep.20906

A. Op-de-beeck, C. Voisset, and B. Bartosch, Characterization of Functional Hepatitis C Virus Envelope Glycoproteins, Journal of Virology, vol.78, issue.6, pp.2994-3002, 2004.
DOI : 10.1128/JVI.78.6.2994-3002.2004

C. Voisset, N. Callens, E. Blanchard, O. De-beeck, A. Dubuisson et al., High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I, Journal of Biological Chemistry, vol.280, issue.9, pp.7793-7802, 2005.
DOI : 10.1074/jbc.M411600200
URL : https://hal.archives-ouvertes.fr/hal-00105456

T. Von-hahn, B. Lindenbach, and A. Boullier, Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells, Hepatology, vol.122, issue.5, pp.932-974, 2006.
DOI : 10.1002/hep.21139

M. Dreux, T. Pietschmann, and C. Granier, High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI, Journal of Biological Chemistry, vol.281, issue.27, pp.18285-95, 2006.
DOI : 10.1074/jbc.M602706200
URL : https://hal.archives-ouvertes.fr/hal-00313930

C. Voisset, A. Op-de-beeck, and P. Horellou, High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry, Journal of General Virology, vol.87, issue.9, pp.2577-81, 2006.
DOI : 10.1099/vir.0.81932-0
URL : https://hal.archives-ouvertes.fr/hal-00105505

P. Farci, A. Shimoda, and A. Coiana, The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies, Science, vol.288, issue.5464, pp.339-383, 2000.
DOI : 10.1126/science.288.5464.339

M. Dreux and F. Cosset, The scavenger receptor BI and its ligand, HDL: partners in crime against HCV neutralizing antibodies, Journal of Viral Hepatitis, vol.80, issue.s1, pp.68-76, 2007.
DOI : 10.1038/nature05654

J. Zhong, P. Gastaminza, and J. Chung, Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host, Journal of Virology, vol.80, issue.22, pp.11082-93, 2006.
DOI : 10.1128/JVI.01307-06

P. Pugach, S. Kuhmann, and J. Taylor, The prolonged culture of human immunodeficiency virus type 1 in primary lymphocytes increases its sensitivity to neutralization by soluble CD4, Virology, vol.321, issue.1, pp.8-22, 2004.
DOI : 10.1016/j.virol.2003.12.012

R. Marsh, A. Connor, E. Gias, and G. Toms, Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture, Journal of Medical Virology, vol.97, issue.6, pp.829-866, 2007.
DOI : 10.1002/jmv.20892

P. Kwong, M. Doyle, and D. Casper, HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites, Nature, vol.85, issue.6916, pp.678-82, 2002.
DOI : 10.1128/JVI.74.4.1961-1972.2000

M. Gal-tanamy, Z. Keck, and M. Yi, In vitro selection of a neutralization-resistant hepatitis C virus escape mutant, Proceedings of the National Academy of Sciences, vol.105, issue.49, pp.19450-19455, 2008.
DOI : 10.1073/pnas.0809879105

J. Moore and . Hiv, Back to primary school, Nature, vol.376, issue.6536, pp.115-1995
DOI : 10.1038/376115a0